AMEI's Current Trends in Diagnosis & Treatment

Register      Login

VOLUME 1 , ISSUE 1 ( January-June, 2017 ) > List of Articles


Oral Submucous Fibrosis: An Overview

Ramandeep S Narang

Citation Information : Narang RS. Oral Submucous Fibrosis: An Overview. Curr Trends Diagn Treat 2017; 1 (1):22-26.

DOI: 10.5005/jp-journals-10055-0005

License: NA

Published Online: 01-06-2017

Copyright Statement:  NA


How to cite this article

Narang RS, Arora A. Oral Submucous Fibrosis: An Overview. Curr Trends Diagn Treat 2017;1(1):22-26.

  1. Oral submucous fibrosis: etiology, pathogenesis, and future research. Bull World Health Organ 1994;72(6):985-996.
  2. Oral submucous fibrosis: an update. Clin Cosmet Investig Dermatol 2015 Apr;8:193-204.
  3. Atrophia idiopathica (tropica) mucosae oris. Demonstrated at the Eleventh International Dental Congress, London; 1952 (cited by Sirsat and Khanolkar, Ind J Med Sci 1962;16:189-197).
  4. Submucous fibrosis of the palate and pillars. Ind J Otolaryngol 1953;4(1):1-4.
  5. Betel nut: a common drug used by naturalized citizens from India, Far East Asia, and the South Pacific Islands. Ann Emerg Med 1999 Aug;34(2):238-243.
  6. Cultural and dietary risk factors of oral cancer and precancer – a brief overview. Oral Oncol 2001 Apr;37(3):205-210.
  7. Betel quid chewing in rural Bangladesh: prevalence, predictors and relationship to blood pressure. Int J Epidemiol 2012 Apr;41(2):462-471.
  8. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966 Dec;22(6):764-779.
  9. Epidemiologic study of 600 villagers of oral precancerous lesions in Bilugyun: preliminary report. Community Dent Oral Epidemiol 1982 Jun;10(3):152-155.
  10. Betel-nut chewing and submucous fibrosis in Durban. S Afr Med J 1988 Dec;74(11):568-571.
  11. Oral submucous fibrosis in India: a new epidemic? Natl Med J India 1998 May-Jun;11(3):113-116.
  12. The prevalence of oral mucosal lesions in patients visiting a dental school in Southern India. Indian J Dent Res 2008 Apr-Jun;19(2):99-103.
  13. Cancer of the buccal mucosa: a clinical study of 650 cases in Indian patients. Cancer 1956 May-Jun;9(3):431-435.
  14. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 1985 Dec;13(6):340-341.
  15. Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol 2009 May;1(1):10.
  16. Molecular pathogenesis of oral submucous fibrosis – a collagen metabolic disorder. J Oral Pathol Med 2005 Jul;34(6):321-328.
  17. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature. J Can Dent Assoc 2008 Oct;74(8):735-740.
  18. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004;85:1-334.
  19. Betel quid chewing elevates human exposure to arsenic, cadmium and lead. J Hazard Mater 2011 Jun;190(1-3):69-74.
  20. Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 2000 Jul;29(6):241-248.
  21. Collagenase activity in oral submucous fibrosis. Proc Natl Sci Counc Repub China B 1992 Apr;16(2):106-110.
  22. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis. Oral Dis 2007 Mar;13(2):234-238.
  23. Cytotoxicity and arecoline mechanisms in human gingival fibroblasts in vitro. Clin Oral Investig 2001 Mar;5(1):51-56.
  24. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 2006 Jul;42(6):561-568.
  25. Estimation and comparison of copper content in raw areca nuts and commercial areca nut products: implications in increasing prevalence of oral submucous fibrosis (OSMF). J Clin Diagn Res 2014 Jan;8(1):247-249.
  26. Pathogenesis of oral submucous fibrosis. J Cancer Res Ther 2012 Apr-Jun;8(2):199-203.
  27. The bioavailability of copper. New York: Plenum Press; 1991.
  28. Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet 1997 May;349(9063):1447.
  29. Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 2001 Sep;30(8):465-470.
  30. The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med 1999 Jul;28(6):246-251.
  31. Quantitative analysis of serum levels of trace elements in patients with oral submucous fibrosis and oral squamous cell carcinoma: a randomized cross-sectional study. J Oral Maxillofac Pathol 2014 Jan;18(1):46-51.
  32. Clinical and functional staging of oral submucous fibrosis. Br J Oral Maxillofac Surg 2000 Feb;38(1):12-15.
  33. Comparative study of clinicofunctional staging of oral submucous fibrosis with qualitative analysis of collagen fibers under polarizing microscopy. Indian J Dent Res 2009 Jul-Sep;20(3):271-276.
  34. Proposed new grading of oral submucous fibrosis based on cheek flexibility. J Clin Exp Dent 2014 Jul;6(3):e255-e258.
  35. An alternative pathogenetic pathway for oral submucous fibrosis (OSMF). Med Hypotheses 1989 Sep;30(1):35-37.
  36. High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. J Oral Pathol Med 2002 Aug;31(7):402-409.
  37. Diagnosis of oral submucous fibrosis with optical coherence tomography. J Biomed Opt 2009 Sep-Oct;14(5):054008.
  38. Areca nut chewing and systemic inflammation: evidence of a common pathway for systemic diseases. J Inflamm (Lond) 2012 Jun;9(1):22.
  39. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 1995 Oct;24(9):402-406.
  40. Review of drug treatment of oral submucous fibrosis. Oral Oncol 2012 May;48(5):393-398.
  41. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 Feb;103(2):207-213.
  42. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991 Aug;49(8):788-791.
  43. Oral submucous fibrosis – a new treatment regimen. J Oral Maxillofac Surg 1988 Oct;46(10):830-833.
  44. Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian J Med Res 2010 May;131:665-669.
  45. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. J Oral Pathol Med 2009 Feb;38(2):220-226.
  46. Oral submucous fibrosis: its pathogenesis and management. Br Dent J 1986 Jun;160(12):429-434.
  47. Importance of coronoidotomy and masticatory muscle myotomy in surgical release of trismus caused by submucous fibrosis. Plast Reconstr Surg 2004 Jun;113(7):1949-1954.
  48. Lack of reliable evidence for oral submucous fibrosis treatments. Evid Based Dent 2009 Mar;10(1):8-9.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.